CAS Medical Systems Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
10,362.20
7,601.50
10,053.40
5,925.60
8,903.50
Depreciation, Depletion & Amortization
1,392.50
1,672.50
1,363.30
1,011.10
1,025.80
Other Funds
-
5,000.00
-
-
-
Funds from Operations
8,044.70
4,711.60
5,470.10
5,282.90
5,227.60
Changes in Working Capital
707.70
543.10
664.50
722.40
552.30
Net Operating Cash Flow
8,752.30
5,254.70
4,805.60
6,005.30
4,675.40
Capital Expenditures
1,400.50
1,632.10
1,225.20
1,358.70
663.90
Sale of Fixed Assets & Businesses
-
-
-
3,303.70
4,527.20
Purchase/Sale of Investments
1,250.80
-
-
-
-
Net Investing Cash Flow
246.50
1,615.20
618.50
3,821.90
5,054.90
Issuance/Reduction of Debt, Net
1,500.00
8,052.10
1,456.80
101.40
234.10
Net Financing Cash Flow
7,451.10
3,174.30
7,220.70
143.80
215.20
Net Change in Cash
1,054.80
3,695.60
3,033.60
2,039.60
164.30
Free Cash Flow
9,982.70
6,763.90
5,934.90
7,270.40
5,271.80
Deferred Taxes & Investment Tax Credit
-
-
209.20
1,424.10
1,745.40
Other Sources
396.20
16.80
1,847.10
1,876.80
1,191.50
Change in Capital Stock
5,951.10
122.30
8,677.60
42.40
18.90
Other Uses
-
-
3.40
-
-

About CAS Medical Systems

View Profile
Address
44 East Industrial Road
Branford Connecticut 06405
United States
Employees -
Website http://www.casmed.com
Updated 09/14/2018
CAS Medical Systems, Inc. develops, manufactures and markets non-invasive patient monitoring products that are vital to patient care. Its products include the FORE-SIGHT Absolute Tissue Oximeter and sensors, and its traditional monitoring products which include MAXNIBP blood pressure measurement technology. The company's products are designed to provide accurate, non-invasive, biologic measurements that guide clinicians to provide better patient care.